Eli Lilly (LLY) Q4 Earnings Miss, COVID Therapies Aid Sales

Eli Lilly (LLY) Q4 Earnings Miss, COVID Therapies Aid Sales

Source: 
Yahoo/Zacks.com
News Tags: 
snippet: 

Eli Lilly and Company LLY reported fourth-quarter 2021 adjusted earnings per share of $2.49, which missed the Zacks Consensus Estimate of $2.51. Earnings, however, rose 8% year over year, driven by higher operating profits.